Rachel Humphrey

Affiliations

  • Director at Xilio Therapeutics Inc. (XLO), 2021-10-22
  • Chief Medical Officer at Black Diamond Therapeutics Inc. (BDTX), 2021-02-19
  • Chief Medical Officer at Cytomx Therapeutics Inc. (CTMX), 2019-01-30
  • Evp And Chief Medical Officer at Mirati Therapeutics Inc. (MRTX), 2013-07-12
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CTMX $30.00 16,160 Officer 30,234 2018-03-02 Filing
CTMX $30.00 23,840 Officer 30,234 2018-02-28 Filing